Cargando…
Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
Autor principal: | Eun, Chang Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221852/ https://www.ncbi.nlm.nih.gov/pubmed/28053295 http://dx.doi.org/10.5009/gnl16574 |
Ejemplares similares
-
Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
por: Charabaty, Aline
Publicado: (2020) -
Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients
por: Kim, Seong-Eun
Publicado: (2017) -
Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020) -
An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
por: Patel, Rajan N., et al.
Publicado: (2020) -
Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
por: Marquez-Megias, Silvia, et al.
Publicado: (2022)